Search Within

GDMT, Medicine

Formats
  1. Journal Article (921)
  2. Meeting Abstract (826)
  3. Review (46)
  4. Book Section (38)
  5. Editorial (29)
  6. Guidelines (19)
  7. Correspondence (7)
  8. Research Letter (1)
Groups
  1. Gynecology Disease Management Team (1887)
  2. Department of Medicine (1878)
  3. Solid Tumor Oncology Division (1876)
  4. Gynecologic Medicine Service (1836)
  5. Surgery (578)
  6. GDMT, Surgery (462)

More Groups

People
  1. Carol Aghajanian (609)
  2. Martee Hensley (290)
  3. Nadeem Abu-Rustum (277)
  4. Roisin O'Cearbhaill (272)
  5. Vicky Makker (265)
  6. Paul Sabbatini (262)

More People

Years
  1. 2025 (50)
  2. 2024 (159)
  3. 2023 (165)
  4. 2022 (196)
  5. 2021 (146)
  6. 2020 (173)

More Years

Publications
  1. Gynecologic Oncology (416)
  2. Journal of Clinical Oncology (415)
  3. International Journal of Gynecological Cancer (148)
  4. Annals of Oncology (106)
  5. Clinical Cancer Research (62)
  6. Cancer (37)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (447)
  3. Lippincott Williams & Wilkins (173)
  4. American Association for Cancer Research (137)
  5. Oxford University Press (128)
  6. Nature Publishing Group (71)

More Publishers

Results (1887)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of growth factor (GF) omission during paclitaxel (T) for women with early breast carcinoma (BC)
    Meeting Abstract

    Sugarman, S. M.; Wasserheit, C.; Hodgman, E.; Coglianese, M. E.; D'alessandro, A.; Fornier, M.; Troso-Sandoval, T.; D'Andrea, G.; Drullinsky, P.; Lake, D.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • A SARC multicenter phase III study of gemcitabine (G) vs. gemcitabine and docetaxel (G+D) in patients (pts) with metastatic soft tissue sarcomas (STS)
    Meeting Abstract

    Maki, R. G.; Hensley, M. L.; Wathen, J. K.; Patel, S. R.; Priebat, D. A.; Okuno, S.; Reinke, D.; Thall, P. F.; Benjamin, R. S.; Baker, L. H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I study of MORAb-003, a humanized anti-folate receptor-alpha monoclonal antibody, in platinum resistant ovarian cancer
    Meeting Abstract

    Konner, J. A.; Ahmed, S.; Gerst, S.; Els, N. V.; Pezzulli, S.; Sabbatini, P.; Hensley, M.; Dupont, J.; Tew, W.; Aghajanian, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • A phase I study of pemetrexed (P) plus gemcitabine (G) in relapsed ovarian cancer (OC): Dosing results and evidence of activity
    Meeting Abstract

    Hensley, M. L.; Derosa, F.; Gerst, S. R.; Sabbatini, P.; Dupont, J.; Konner, J.; Goss, T.; Orlando, M.; Wang, Y.; Aghajanian, C.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Phase I safety and immunogenicity study of NY-ESO-1b peptide and Montanide ISA-51 vaccination of patients with ovarian cancer (OC) in high risk first remission
    Meeting Abstract

    Diefenbach, C. S. M.; Sabbatini, P.; Aghajanian, C.; Spriggs, D.; Lee, H.; Pezzulli, S.; Jungbluth, A. A.; Old, L. J.; Gnjatic, S.; Dupont, J.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Updated cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Norton, L.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Mature cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Fornier, M.; Sugarman, S.; Troso, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; George, R.; more...
    Breast Cancer Research and Treatment (2006)

    Fulltext@MSK | Save
  • Final results from a phase I trial of ixabepilone in patients with advanced malignancies and lymphoma
    Meeting Abstract

    Aghajanian, C.; O'connor, O.; Cohen, M.; Peck, R.; Burris, H.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Clinical activity of Pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: Potential predictive relationship with tumor HER2 activation status
    Journal Article

    Gordon, M. S.; Matei, D.; Aghajanian, C.; Matulonis, U. A.; Brewer, M.; Fleming, G. F.; Hainsworth, J. D.; Garcia, A. A.; Pegram, M. D.; Schilder, R. J.; more...
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: A retrospective study
    Journal Article

    Sovak, M. A.; Hensley, M. L.; Dupont, J.; Ishill, N.; Alektiar, K. M.; Abu Rustum, N.; Barakat, R.; Chi, D. S.; Sabbatini, P.; Spriggs, D. R.; more...
    Gynecologic Oncology (2006)

    Fulltext@MSK | Save